The Challenge of Analytical Quality in the 21st Century
Graham Clarke, Bristol-Myers Squibb

Bullet Points from Genotoxic Impurities Sub-Droup Discussion
(7.7Mb, may open slowly)

Setting Early Development Specifications
Sam McClintock, MccL Pharma Consulting Inc

Sample Preparation - Who Cares
Adele Patterson, Graham Clarke, Bristol-Myers Squibb

Are we Certain of Our Uncertainty
Vicki Barwick, LGC

Does the BCS have any relevance to the Analyst
Dónal Murphy, David Holt, AstraZeneca

Qualification and Validation of Analytical Methods: Is the Cost Worthwhile
Sam McClintock, MccL Pharma Consulting Inc